Skip to main content

Use of anabolic steroid therapy in critically ill ICU patients

Critical illness leads to a loss of lean body mass (LBM) and is associated with impaired immune function and wound healing, increased infection, and poorer outcomes [1, 2]. Aggressive nutritional support can decrease net catabolic losses by only ~50%, therefore other methods need to be examined. We initiated anabolic steroid therapy (AS) (nandrolone intramuscular injection, once weekly × three doses) on 10 critically ill patients. Criteria for AS: moderate to severe malnutrition, ICU stay > 14 days, tolerating enteral feeds, and exhibiting poor response to nutritional support. Feeds were 130–150% of measured energy expenditure and protein at 2.0–2.5 g/kg per day. Response was monitored by nitrogen balance and LBM.

Eight of 10 patients exhibited a good response to AS, with attainment of positive nitrogen balance and improvement in skeletal and visceral protein levels. AS may be useful as adjunctive therapy for malnourished, critically ill patients for protein repletion.

Table 1

References

  1. Chang DW, DeSanti L, Demling RH: Shock 1998, 10: 155-160.

    CAS  Article  PubMed  Google Scholar 

  2. Ferrando AA, Sheffield-Moore M, Wolf SE, et al.: Crit Care Med 2001, 29: 1936-1942. 10.1097/00003246-200110000-00015

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Pikul, J., Sharpe, M. Use of anabolic steroid therapy in critically ill ICU patients. Crit Care 7, P014 (2003). https://doi.org/10.1186/cc1903

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/cc1903

Keywords

  • Critical Illness
  • Lean Body Mass
  • Adjunctive Therapy
  • Nutritional Support
  • Anabolic Steroid